{"url_path":"/sec/si/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1699350/0001699350-26-000035-index.html","accession_number":"0001699350-26-000035","cik":"0001699350","ticker":"SI","issuer_name":"SHOULDER INNOVATIONS, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1699350/0001699350-26-000035-index.html","primary_entity_key":"0001699350","primary_entity_name":"SHOULDER INNOVATIONS, INC."},"word_count":44,"has_tables":true,"body_markdown":"Item 5. Other Information\n\nOn March 13, 2026, Matthew Ahearn, Chief Operating Officer, adopted a trading plan intended to satisfy Rule 10b5-1(c), to sell up to 67,500 shares of our common stock between March 13, 2026 and February 15, 2027, subject to certain conditions."}